Bharat Biotech

Clinical trial of Bharat Biotech's Nasal Corona Vaccine to take place at Delhi AIIMS

Bharat Biotech's Covid Nasal Vaccine Gets Regulator's Nod For Holding Phase 2, 3 Clinical Trials

Bharat Biotech’s Covaxin To Get WHO Emergency Use Authorisation Nod By September: Report

Bharat Biotech Achieves Another Milestone As Covaxin Receives GMP Certificate From Hungary

Bharat Biotech Terminates MoU With Brazilian Partners After Controversy Over Covaxin Deal

Centre Revises Rates For Procuring Covishield & Covaxin, Places Order To Get 66 Crore Doses: Report

Covaxin Closer To WHO Approval? Covid-19 Vaccine Trial Data 'Looks Good', Says Chief Scientist

Coronavirus HIGHLIGHTS: Over 2 Crore 'Unutilised' COVID-19 Vaccine Doses Still Available With States, Says Govt

Coronavirus HIGHLIGHTS: Goa Govt Allows Bars, Restaurants To Function With 50% Seating Capacity

Coronavirus HIGHLIGHTS: Delhi Reports 86 New Covid Cases, 5 Deaths In Last 24 Hours

'Covaxin Found To Be 77.8% Effective In Final Analysis Of Phase III Trials', Claims Bharat Biotech

Coronavirus HIGHLIGHTS: Zydus Cadila Application For Zycov Jab Under Evaluation, Says Niti Aayog